Alliance Global analyst Jake Sekelsky lowered the firm’s price target on IperionX (IPX) to $53 from $60 and keeps a Buy rating on the shares. The firm cites the company’s update to share count for the target cut. IperionX’s announced that titanium production at its facility in Virginia recently advanced from the commissioning stage to continuous operation, which sets the stage for a strong second half of 2026, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IPX: